We’re in the midst of a paradigm shift in biomarker science. | The right biomarker signature can de-risk trials, guide ...

Increasing adoption of risk-based quality management Thanks to both COVID-19 pandemic restrictions and technological advancements, the remote risk monitoring process has garnered more attention ...

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement ...

Enterprise risk management (ERM) is a holistic, top-down approach that assesses how risks affect an organization and devises plans on how to approach different risks.

"On behalf of the entire team, I'm thrilled to welcome Elaine and Kim to QT Imaging," said Dr. Raluca Dinu, CEO of QTI. "They bring deep clinical expertise and leadership that will be critical as we ...

Dr. Wei Wang is a researcher at Beijing Children's Hospital whose work focuses on pediatric tumor immunology and the development ... risk but also the "why." This transparency fosters more informed ...